New insider activity at Radnet ( (RDNT) ) has taken place on September 15, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cornelis Wesdorp, the President and CEO of Digital Health, has recently sold 500 shares of Radnet stock, amounting to a total transaction value of $36,065.
Recent Updates on RDNT stock
In the last 24 hours, RadNet’s stock has seen significant positive movements, with its price target being raised by both Truist and Barclays. Truist increased its price target from $74 to $81, driven by robust demand trends in RadNet’s core imaging centers and strategic investments in Digital Health, alongside potential for growth through mergers and acquisitions. Barclays raised its target from $60 to $79, citing productivity gains and volume growth from the Q2 report, which are expected to continue into 2026, setting a favorable outlook for the stock. Additionally, RadNet’s stock rose by 21%, reflecting investor confidence following its record revenue achievement and raised 2025 outlook.
Spark’s Take on RDNT Stock
According to Spark, TipRanks’ AI Analyst, RDNT is a Neutral.
Radnet’s overall stock score is driven by strong technical momentum and positive earnings call highlights, including record revenue and strategic acquisitions. However, profitability challenges and a negative P/E ratio weigh on the valuation score, limiting the overall score.
To see Spark’s full report on RDNT stock, click here.
More about Radnet
YTD Price Performance: 5.50%
Average Trading Volume: 761,963
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.69B